Skip to content

Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function

Hämeenlinna Metabolic Syndrome Research Program (HMS): Effects of Dietary Cold-pressed Turnip Rapeseed Oil and Milk Fat on Serum Lipids, Oxidized LDL, Arterial Elasticity and Platelet Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01119690
Acronym
HMS-03
Enrollment
43
Registered
2010-05-07
Start date
2004-09-30
Completion date
2008-06-30
Last updated
2010-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

Dietary, Cross-Over Study, Lipids, Rapeseed oil, Butter, Milk Fat, Unsaturated Fat, Saturated Fat, Oxidized LDL, Platelet Function, Arterial Elasticity

Brief summary

In this study, the effects of dietary intake of cold-pressed turnip rapeseed oil (CTPRO) and milk fat are compared in men with metabolic syndrome having already participated in HMS-02 study.

Detailed description

This open and balanced cross-over study consists of two dietary treatment phases (either Virgino (R) CTPRO or butter) for 6 to 8 weeks. They are separated from each other with an eight-week washout period. At the end of both periods and 12-hour fasting an oral glucose-fat tolerance test is carried out. Except glucose, the test consists cream (after the butter phase) and CTPRO (after the CTPRO phase). Otherwise, the subjects (n=43) are asked to maintain their normal dietary habits.

Interventions

DIETARY_SUPPLEMENTCold-pressed turnip rapeseed oil (CTPRO)

1. In the dietary period of 6 to 8 weeks: CTPRO 37 ml/day. 2. In the 5-hour oral glucose and fat tolerance test: glucose and CTPRO.

DIETARY_SUPPLEMENTmilk fat

1. In dietary period of 6 to 8 weeks: 37.5 grams of butter. 2. In the 5-hour oral glucose and fat tolerance test: glucose and cream

Sponsors

Linnan Klinikka Oy
CollaboratorOTHER
MTT Agrifood Research Finland
CollaboratorUNKNOWN
Finnish Red Cross Blood Service
CollaboratorOTHER
Kanta-Häme Central Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
31 Years to 66 Years
Healthy volunteers
No

Inclusion criteria

* 43 men with metabolic syndrome having already participated in the HMS-02 Study * Willing to participate in a demanding dietary study

Design outcomes

Primary

MeasureTime frameDescription
Circulating lipids6 to 8 weeksAt the end of both 6- to 8-week dietary periods, fasting values of circulating lipids including oxidized LDL are determined
Platelet function6 to 8 weeksAt the end of both 6- to 8-week dietary periods, platelet function is determined
Glucose tolerance5 hoursDuring a 5-hour oral glucose-fat tolerance test the area under curve of plasma glucose and insulin concentration is determined

Secondary

MeasureTime frameDescription
Arterial elasticity6 to 8 weeksAt the end of both 6- to 8-week dietary periods, arterial elasticity is determined
Serum triglyceride AUC5 hoursDuring a 5-hour oral glucose-fat tolerance test the area under curve of serum triglyceride concentration is determined
Platelet function5 hoursDuring a 5-hour oral glucose-fat tolerance test the platelet function is determined

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026